Pericardial Window for Malignant Pericardial Effusion with Lung Cancer Have Worse Long-Term Outcomes than Other Cancers

Robert J. Chen, Ta-Chung Shen, Zubair Hashmi

Research output: Contribution to conferencePoster

Abstract

For malignant pericardial effusion (MPE), we observed worse outcomes in lung than other cancer cases. Using electronic hospital information system, we analyzed the data to test the hypothesis that MPE with lung cancer has
worse clinical outcomes than other cancers. From 08/2005 to 06/2016, 52 cases of pericardial window with MPE (30 cases of lung cancer) were retrieved and analyzed. Comparing to non-lung cancer, hospital mortality and
length of stay did not differ significantly, but lung cancer cases had worse overall survival and Kaplan-Meier survival. Open pericardial window for lung cancer-related MPE should be further evaluated for risks and benefits.
Original languageEnglish
DOIs
Publication statusPublished - May 1 2017
Externally publishedYes

Fingerprint

Pericardial Effusion
Lung Neoplasms
Neoplasms
Hospital Information Systems
Cancer Care Facilities
Hospital Mortality

Cite this

Pericardial Window for Malignant Pericardial Effusion with Lung Cancer Have Worse Long-Term Outcomes than Other Cancers. / Chen, Robert J.; Shen, Ta-Chung; Hashmi, Zubair.

2017.

Research output: Contribution to conferencePoster

@conference{ccb4704759d4405f937cd1c209be27d4,
title = "Pericardial Window for Malignant Pericardial Effusion with Lung Cancer Have Worse Long-Term Outcomes than Other Cancers",
abstract = "For malignant pericardial effusion (MPE), we observed worse outcomes in lung than other cancer cases. Using electronic hospital information system, we analyzed the data to test the hypothesis that MPE with lung cancer hasworse clinical outcomes than other cancers. From 08/2005 to 06/2016, 52 cases of pericardial window with MPE (30 cases of lung cancer) were retrieved and analyzed. Comparing to non-lung cancer, hospital mortality andlength of stay did not differ significantly, but lung cancer cases had worse overall survival and Kaplan-Meier survival. Open pericardial window for lung cancer-related MPE should be further evaluated for risks and benefits.",
author = "Chen, {Robert J.} and Ta-Chung Shen and Zubair Hashmi",
note = "M1 - 313 doi:10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4599",
year = "2017",
month = "5",
day = "1",
doi = "10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4599",
language = "English",

}

TY - CONF

T1 - Pericardial Window for Malignant Pericardial Effusion with Lung Cancer Have Worse Long-Term Outcomes than Other Cancers

AU - Chen, Robert J.

AU - Shen, Ta-Chung

AU - Hashmi, Zubair

N1 - M1 - 313 doi:10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4599

PY - 2017/5/1

Y1 - 2017/5/1

N2 - For malignant pericardial effusion (MPE), we observed worse outcomes in lung than other cancer cases. Using electronic hospital information system, we analyzed the data to test the hypothesis that MPE with lung cancer hasworse clinical outcomes than other cancers. From 08/2005 to 06/2016, 52 cases of pericardial window with MPE (30 cases of lung cancer) were retrieved and analyzed. Comparing to non-lung cancer, hospital mortality andlength of stay did not differ significantly, but lung cancer cases had worse overall survival and Kaplan-Meier survival. Open pericardial window for lung cancer-related MPE should be further evaluated for risks and benefits.

AB - For malignant pericardial effusion (MPE), we observed worse outcomes in lung than other cancer cases. Using electronic hospital information system, we analyzed the data to test the hypothesis that MPE with lung cancer hasworse clinical outcomes than other cancers. From 08/2005 to 06/2016, 52 cases of pericardial window with MPE (30 cases of lung cancer) were retrieved and analyzed. Comparing to non-lung cancer, hospital mortality andlength of stay did not differ significantly, but lung cancer cases had worse overall survival and Kaplan-Meier survival. Open pericardial window for lung cancer-related MPE should be further evaluated for risks and benefits.

U2 - 10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4599

DO - 10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A4599

M3 - Poster

ER -